Thymoma Type B3
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents (NCT04710628) | MedSIR | 2021-09-21 |
| Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM) (NCT03134118) | European Organisation for Research and Treatment of Cancer - EORTC | 2018-04-11 |
| Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy (NCT02307500) | Istituto Clinico Humanitas | 2014-12-01 |
Track Thymoma Type B3 automatically
Every clearance here is in the API, with alerts when new ones post.